295 related articles for article (PubMed ID: 33501759)
21. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
[TBL] [Abstract][Full Text] [Related]
22. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice.
Lonetti G; Angelucci A; Morando L; Boggio EM; Giustetto M; Pizzorusso T
Biol Psychiatry; 2010 Apr; 67(7):657-65. PubMed ID: 20172507
[TBL] [Abstract][Full Text] [Related]
23. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
24. Mosaicism of common pathogenic MECP2 variants identified in two males with a clinical diagnosis of Rett syndrome.
Cooley Coleman JA; Fee T; Bend R; Louie R; Annese F; Stallworth J; Worthington J; Buchanan CB; Everman DB; Skinner S; Friez MJ; Jones JR; Spellicy CJ
Am J Med Genet A; 2022 Oct; 188(10):2988-2998. PubMed ID: 35924478
[TBL] [Abstract][Full Text] [Related]
25. WGCNA Identifies Translational and Proteasome-Ubiquitin Dysfunction in Rett Syndrome.
Haase F; Gloss BS; Tam PPL; Gold WA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576118
[TBL] [Abstract][Full Text] [Related]
26. Brief report: MECP2 mutations in people without Rett syndrome.
Suter B; Treadwell-Deering D; Zoghbi HY; Glaze DG; Neul JL
J Autism Dev Disord; 2014 Mar; 44(3):703-11. PubMed ID: 23921973
[TBL] [Abstract][Full Text] [Related]
27. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
Mol Autism; 2017; 8():56. PubMed ID: 29090078
[TBL] [Abstract][Full Text] [Related]
28. Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.
Carrette LLG; Blum R; Ma W; Kelleher RJ; Lee JT
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8185-8190. PubMed ID: 30038001
[TBL] [Abstract][Full Text] [Related]
29. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
[TBL] [Abstract][Full Text] [Related]
30. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
31. An Astrocytic Influence on Impaired Tonic Inhibition in Hippocampal CA1 Pyramidal Neurons in a Mouse Model of Rett Syndrome.
Dong Q; Kim J; Nguyen L; Bu Q; Chang Q
J Neurosci; 2020 Aug; 40(32):6250-6261. PubMed ID: 32616668
[TBL] [Abstract][Full Text] [Related]
32. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
33. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
34. The relationship of Rett syndrome and MECP2 disorders to autism.
Neul JL
Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951
[TBL] [Abstract][Full Text] [Related]
35. The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.
Neul JL; Benke TA; Marsh ED; Skinner SA; Merritt J; Lieberman DN; Standridge S; Feyma T; Heydemann P; Peters S; Ryther R; Jones M; Suter B; Kaufmann WE; Glaze DG; Percy AK
Am J Med Genet B Neuropsychiatr Genet; 2019 Jan; 180(1):55-67. PubMed ID: 30536762
[TBL] [Abstract][Full Text] [Related]
36. Atypical Rett syndrome in a girl with mosaic triple X and MECP2 variant.
Takahashi S; Takeguchi R; Kuroda M; Tanaka R
Mol Genet Genomic Med; 2020 Mar; 8(3):e1122. PubMed ID: 31943886
[TBL] [Abstract][Full Text] [Related]
37. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
38. Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes.
Flores Gutiérrez J; Natali G; Giorgi J; De Leonibus E; Tongiorgi E
Exp Neurol; 2022 Jul; 353():114056. PubMed ID: 35358499
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D Supplementation Rescues Aberrant NF-κB Pathway Activation and Partially Ameliorates Rett Syndrome Phenotypes in
Ribeiro MC; Moore SM; Kishi N; Macklis JD; MacDonald JL
eNeuro; 2020; 7(3):. PubMed ID: 32393583
[TBL] [Abstract][Full Text] [Related]
40. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
